Patent 8937182 was granted and assigned to Metabolic Solutions Development Company on January, 2015 by the United States Patent and Trademark Office.
The present invention provides novel methods for synthesizing PPARγ sparing compounds, e.g., thiazolidinediones, that are useful for preventing and/or treating metabolic disorders such as diabetes, obesity, hypertension, and inflammatory diseases.